Get started
Author

Adriana Ionelia Apostol

Mid- and low-rectal cancer: laparoscopic vs open treatment—short- and long-term results. Meta-analysis of randomized controlled trials
2021 · Mario Schietroma, Lucia Romano, et al. · International Journal of Colorectal Disease · 22
Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant
2025 · Adriana I. Apostol, Joanne Kotsopoulos, et al. · Gynecologic Oncology · 7
Focus on Trabectedin in Ovarian Cancer: What Do We Still Need to Know?
2024 · Serena Maria Boccia, Carolina Maria Sassu, et al. · Drug Design Development and Therapy · 7
PDF
Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2
2026 · Adriana I. Apostol, Jacek Gronwald, et al. · Journal of Clinical Oncology · 6
Integrating clinical-molecular data to predict PARP inhibitors efficacy in advanced ovarian cancer patients after interval cytoreductive surgery
2025 · Claudia Marchetti, Raffaella Ergasti, et al. · Gynecologic Oncology · 6
PDF
Effects of niraparib dose reduction on short-term outcomes in ovarian cancer patients
2024 · Matteo Bruno, Adriana Ionelia Apostol, et al. · International Journal of Gynecological Cancer · 6
Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational status
2024 · Claudia Marchetti, Beyhan Ataseven, et al. · Gynecologic Oncology · 6
PDF
A Modified Basophil Activation Test for the Clinical Management of Immediate Hypersensitivity Reactions to Paclitaxel: A Proof-of-Concept Study
2023 · Marilena La Sorda, Marco Fossati, et al. · Cancers · 6
PDF
The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in BRCA1
2025 · Joanne Kotsopoulos, Adriana I. Apostol, et al. · Current Oncology · 2
PDF
Validation of machine learning-based models to predict and explain the risk of ovarian cancer: a multicentric study on BRCA-mutated patients undergoing risk-reducing salpingo-oophorectomy
2025 · Vera Loizzi, Maria Colomba Comes, et al. · Frontiers in Oncology · 2
PDF
Effects of short-term fasting compared to free diet in ovarian cancer patients: Results from a two-arm pilot randomized trial.
2026 · Claudia Marchetti, Carolina Maria Sassu, et al. · Journal of Clinical Oncology · 1
First-line immunotherapy with or without PARP inhibitors in advanced ovarian cancer: A meta-analysis including bevacizumab use, molecular status, and PD-L1 expression
2026 · Claudia Marchetti, Carolina Maria Sassu, et al. · Critical Reviews in Oncology/Hematology · 1
Predictors of Successful Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery in Management of Ovarian Cancer
2025 · Claudia Marchetti, Gwenael Ferron, et al. · JCO Oncology Practice · 1
PDF
Olaparib dose reduction in BRCA-mutated platinum-sensitive ovarian cancer recurrence: real-world data
2025 · Serena Maria Boccia, Matteo Bruno, et al. · International Journal of Gynecological Cancer · 1
Real-life observational study on niraparib in older patients with primary tubo-ovarian cancer: a focus on safety and efficacy
2025 · Adriana Ionelia Apostol, Matteo Bruno, et al. · International Journal of Clinical Oncology · 1
PDF
Association Between BRCA1 And BRCA2 Mutations With Toxicity From Olaparib In Platinum Sensitive Relapsed High Grade Ovarian Cancer
2025 · Giorgia Russo, Serena Maria Boccia, et al. · International Journal of Gynecological Cancer · 1
Consistent data about the predictive factors of the success of interval debulking surgery (CC0-IDS) in patients with advanced ovarian cancers in two large independent datasets.
2024 · Benoit You, Anna Fagotti, et al. · Journal of Clinical Oncology · 1
PDF
1231 A novel scoring system to predict PARP inhibitors efficacy in ovarian cancer patients undergoing neoadjuvant chemotherapy: findings from an Italian tertiary-care center
2024 · Claudia Marchetti, Raffaella Ergasti, et al. · International Journal of Gynecological Cancer · 1
Projected Benefit of Bilateral Salpingo-Oophorectomy by Age in BRCA Carriers
2026 · Vasily Giannakeas, Adriana I. Apostol, et al. · JAMA Surgery
Robotic surgery across surgical specialties: an Italian survey on implementation, training, and satisfaction levels among trainees and young attendings: on behalf of the Italian Multispecialty Society of Young Surgeons (SPIGC)
2026 · Francesco Del Giudice, Valerio Santarelli, et al. · Updates in Surgery
PDF
85P Efficacy and safety of dostarlimab plus carboplatin–paclitaxel in first-line patients with mismatch repair-deficient or microsatellite instability-high recurrent or primary advanced endometrial cancer: An italian real life experience
2026 · A. Cefaliello, E. Palluzzi, et al. · ESMO Open
PDF
35P Real-world impact of pembrolizumab-based chemoimmunotherapy in recurrent or metastatic cervical cancer: A large retrospective single-center series
2026 · I. Ruscito, M. Marraffa, et al. · ESMO Open
PDF
Prognostic effect of neoadjuvant chemotherapy in gBRCA-mutated compared to gBRCA wild-type patients with advanced HGSOC treated with first-line PARP inhibitor maintenance: A large series propensity score–matching analysis.
2026 · Ilary Ruscito, Adriana Ionelia Apostol, et al. · Journal of Clinical Oncology
The impact of BRCA status on the efficacy of paclitaxel monotherapy in recurrent ovarian cancer
2026 · Giorgia Russo, Adriana Ionelia Apostol, et al. · International Journal of Gynecological Cancer
PDF
Predictive biomarkers for immunotherapy response in ovarian cancer: the role of repair assisted damage detection (RADD)
2026 · Ilary Ruscito, Giorgia Russo, et al. · Expert Review of Clinical Pharmacology
Works count: 45
Citation count: 78
H-index: 6
I10-index: 1
Year
Topic
Type